[Effect of cytoprotectors on lipid metabolism and C-reactive protein in patients with coronary heart disease].
The results of the study parameters lipid profile and C-reactive protein (C-RP) in patients with angina pectoris after applying meksykoru. Combined treatment with meksykoru to correct the atherogenic lipid profile and CRP helped reduce content CRP, total cholesterol, low-density lipoprotein cholesterol, triglycerides, factor aterohenosti and raise HDL cholesterol.
Ie Kh
IeKh
Zaremba
V M
VM
Karpliak
D060050:Angina, Stable / Q000097:blood / Q000188:drug therapy; D000789:Angina, Unstable / Q000097:blood / Q000188:drug therapy; D000975:Antioxidants / Q000008:administration & dosage / Q000627:therapeutic use*; D002097:C-Reactive Protein / Q000378:metabolism*; D019610:Cytoprotection / Q000187:drug effects*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D050356:Lipid Metabolism / Q000187:drug effects*; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000097:blood / Q000188:drug therapy*; D011725:Pyridines / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
D000975:Antioxidants; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008055:Lipids; D011725:Pyridines; C517040:ethylmethylhydroxypyridine succinate; D002097:C-Reactive Protein